Xarelto Linked to Internal Hemorrhaging

Posted on January 18, 2016

Xarelto is the brand name for rivaroxaban, an anticoagulant, or blood thinner. It’;s used to prevent strokes and blood clots in patients suffering from pulmonary embolism (lung blood clots), deep vein thrombosis (internal blood clots), atrial fibrillation (irregular heartbeat), and people who’;ve undergone recent hip or knee replacement surgery. The medication is manufactured by Bayer and marketed by Johnson & Johnson’s Janssen Pharmaceuticals unit as a more convenient alternative to the long used medication warfarin. Xarelto was approved by the U.S. Food and Drug Administration (FDA) in 2011.

Anticoagulants like Xarelto and warfarin prevent blood clots by thinning the patient’s blood. The downside of these medications is that they can cause uncontrollable and excessive bleeding. A simple fall or bump on the head can cause dangerous internal hemorrhaging within the body and the skull.

Xarelto vs. Warfarin

The anticoagulant warfarin has been in use since the 1950s. It requires a patient to follow strict dietary restrictions and constantly monitor their blood. Xarelto was developed so a patient wouldn’t have to take such measures. While the excessive bleeding dangers of warfarin have long been known, it can be counteracted by large doses of vitamin K. There is no known antidote to excessive bleeding caused by Xarelto. Patients treated with Xarelto can be in constant risk of serious injury and death from something as simple as a bruise.

If you have suffered an injury or lost a spouse or family member due to internal hemorrhaging caused by Xarelto, you need to contact a pharmaceutical litigation attorney.

Contact Us

Farah & Farah considers it our mission to stand up to pharmaceutical giants on behalf of medication injury victims. We handle claims nationwide. Call our offices at (800) 533-3555 for a free consultation.


  • This field is for validation purposes and should be left unchanged.